chronic renal failure stage 4
Jump to navigation
Jump to search
Management
- ACE inhibitor or ARB delays progression to ESRD relative to calcium channel blocker (35% vs 39%)[2]
- ACE inhibitor or ARB delays progression to ESRD but not mortality[3]
More general terms
Additional terms
References
- ↑ Centers for Disease Control and Prevention (CDC) Chronic Kidney Disease (CKD) Surveillance Project https://nccd.cdc.gov/ckd/Help.aspx?section=F#3
- ↑ 2.0 2.1 Fu EL et al. Comparative effectiveness of renin-angiotensin system inhibitors and calcium channel blockers in individuals with advanced CKD: A nationwide observational cohort study. Am J Kidney Dis 2021 May; 77:719. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33246024 Free article https://www.ajkd.org/article/S0272-6386(20)31121-5/fulltext
- ↑ 3.0 3.1 Ku E, Inker LA, Tighiouart H et al. Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease : A Systematic Review and Retrospective Individual Participant-Level Meta-analysis of Clinical Trials. Ann Intern Med. 2024. July 2 PMID: https://www.ncbi.nlm.nih.gov/pubmed/38950402 Review. https://www.acpjournals.org/doi/10.7326/M23-3236